DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Naropin (Ropivacaine) - Anaphylactic Shock - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaphylactic Shock (14)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Naropin (Ropivacaine) where reactions include anaphylactic shock. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Naropin side effects in 23 year old female

Reported by a physician from France on 2012-08-06

Patient: 23 year old female

Reactions: Ventricular Tachycardia, Anaphylactic Shock, Laryngeal Oedema, Cardiac Arrest

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Betadine

Carbocaine
    Indication: Anaesthesia
    Start date: 2012-05-30
    End date: 2012-05-30

Cefazolin
    Indication: Prophylaxis
    Start date: 2012-05-30
    End date: 2012-05-30

Midazolam HCL
    Start date: 2012-05-30
    End date: 2012-05-30

Naropin
    Indication: Anaesthesia
    Start date: 2012-05-30
    End date: 2012-05-30

Sufentanil Citrate
    Dosage: 5, once/single administration
    Start date: 2012-05-30
    End date: 2012-05-30

Other drugs received by patient: Birth Control Pill



Possible Naropin side effects in

Reported by a individual with unspecified qualification from France on 2012-08-02

Patient:

Reactions: Hypotension, Hypercapnia, Anaphylactic Shock, Hyperhidrosis, Cardio-Respiratory Arrest, Respiratory Acidosis, Cyanosis, Bronchospasm, Bradycardia, Myocardial Infarction, Hypovolaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Atarax
    Dosage: 50 mg, once
    Administration route: Oral
    Indication: Anaesthetic Premedication
    Start date: 2010-06-17
    End date: 2010-06-17

Diprivan
    Dosage: 100 mg, once
    Start date: 2010-06-17
    End date: 2010-06-17

Diprivan
    Dosage: 200 mg, once
    Indication: General Anaesthesia
    Start date: 2010-06-17
    End date: 2010-06-17

Diprivan
    Dosage: 100 mg, once
    Start date: 2010-06-17
    End date: 2010-06-17

Lyrica
    Dosage: 150 mg, once
    Administration route: Oral
    Indication: Anaesthetic Premedication
    Start date: 2010-06-17
    End date: 2010-06-17

Naropin
    Dosage: 20 mg, once
    Indication: Neuromuscular Blockade
    Start date: 2010-06-17
    End date: 2010-06-17

Rocuronium Bromide
    Dosage: 50 mg, once
    Indication: General Anaesthesia
    Start date: 2010-06-17
    End date: 2010-06-17

Sufentanil Citrate
    Dosage: 10 ?g, once
    Start date: 2010-06-17
    End date: 2010-06-17

Sufentanil Citrate
    Dosage: 40 ?g, once
    Indication: Gait Disturbance
    Start date: 2010-06-17
    End date: 2010-06-17

Other drugs received by patient: Rivotril; [composition Unspecified]; Aluminum Hydroxide (+) Magnesium Carbonate; Acetaminophen; Oxycontin; Nexium; Olmesartan Medoxomil; Desloratadine; Cymbalta



Possible Naropin side effects in female

Reported by a physician from France on 2012-07-10

Patient: female

Reactions: Overdose, Respiratory Arrest, Anaphylactic Shock, Cardiac Arrest, Convulsion

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Naropin
    Start date: 2010-11-28
    End date: 2010-11-28

Naropin
    Indication: Analgesic Therapy
    Start date: 2010-11-28
    End date: 2010-11-28



Possible Naropin side effects in female

Reported by a physician from France on 2012-07-06

Patient: female

Reactions: Overdose, Respiratory Arrest, Anaphylactic Shock, Cardiac Arrest, Convulsion

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Naropin
    Indication: Analgesic Therapy
    Start date: 2010-11-28
    End date: 2010-11-28

Naropin
    Start date: 2010-11-28
    End date: 2010-11-28



Possible Naropin side effects in 23 year old female

Reported by a physician from France on 2012-07-02

Patient: 23 year old female

Reactions: Ventricular Tachycardia, Anaphylactic Shock, Laryngeal Oedema, Cardiac Arrest

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Betadine
    Start date: 2012-05-30

Carbocaine
    Indication: Anaesthesia
    Start date: 2012-05-30
    End date: 2012-05-30

Cefazolin
    Indication: Prophylaxis
    Start date: 2012-05-30
    End date: 2012-05-30

Midazolam HCL
    Start date: 2012-05-30
    End date: 2012-05-30

Naropin
    Indication: Anaesthesia
    Start date: 2012-05-30
    End date: 2012-05-30

Sufentanil Citrate
    Start date: 2012-05-30
    End date: 2012-05-30

Other drugs received by patient: Birth Control Pill



Possible Naropin side effects in male

Reported by a physician from France on 2012-06-18

Patient: male

Reactions: Hypercapnia, Hypotension, Anaphylactic Shock, Hyperhidrosis, Respiratory Acidosis, Cyanosis, Bronchospasm, Bradycardia, Cardiac Arrest, Myocardial Infarction, Hypovolaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Atarax
    Administration route: Oral
    Indication: Anaesthetic Premedication
    Start date: 2010-06-17
    End date: 2010-06-17

Diprivan
    Dosage: three injection as: 200 mg, 100 mg and then 200 mg
    Indication: Induction of Anaesthesia
    Start date: 2010-06-17
    End date: 2010-06-17

Lyrica
    Administration route: Oral
    Indication: Anaesthetic Premedication
    Start date: 2010-06-17
    End date: 2010-06-17

Naropin
    Indication: Neuromuscular Blockade
    Start date: 2010-06-17
    End date: 2010-06-17

Rocuronium Bromide
    Indication: Induction of Anaesthesia
    Start date: 2010-06-17
    End date: 2010-06-17

Sufentanil Citrate
    Dosage: two injection as: 40 mcg and then 10 mcg
    Indication: Gait Disturbance
    Start date: 2010-06-17
    End date: 2010-06-17

Other drugs received by patient: Olmesartan Medoxomil; Clonazepam; Nexium; Oxycontin; Acetaminophen; Desloratadine; Cymbalta; Gaviscon; Innovaire



Possible Naropin side effects in male

Reported by a physician from France on 2012-06-04

Patient: male

Reactions: Anaphylactic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Atarax
    Administration route: Oral
    Indication: Anaesthetic Premedication
    Start date: 2010-06-17
    End date: 2010-06-17

Diprivan
    Dosage: three injection as: 200 mg, 100 mg and then 200 mg
    Indication: Induction of Anaesthesia
    Start date: 2010-06-17
    End date: 2010-06-17

Lyrica
    Administration route: Oral
    Indication: Anaesthetic Premedication
    Start date: 2010-06-17
    End date: 2010-06-17

Naropin
    Indication: Neuromuscular Blockade
    Start date: 2010-06-17
    End date: 2010-06-17

Rocuronium Bromide
    Indication: Induction of Anaesthesia
    Start date: 2010-06-17
    End date: 2010-06-17

Sufentanil Citrate
    Dosage: two injection as: 40 mcg and then 10 mcg
    Indication: Gait Disturbance
    Start date: 2010-06-17
    End date: 2010-06-17

Other drugs received by patient: Cymbalta; Oxycontin; Gaviscon; Acetaminophen; Olmesartan Medoxomil; Desloratadine; Clonazepam; Innovaire; Nexium



Possible Naropin side effects in male

Reported by a physician from Germany on 2012-04-16

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Urticaria, Anaphylactic Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Naropin
    Indication: Analgesic Therapy

Propofol
    Indication: Stupor

Other drugs received by patient: Nimbex; Remifentanil



Possible Naropin side effects in female

Reported by a consumer/non-health professional from Russian Federation on 2012-02-27

Patient: female

Reactions: Dyspnoea, Tachycardia, Adverse Drug Reaction, Cardiopulmonary Failure, Anaphylactic Shock, Blood Pressure Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Naropin

Other drugs received by patient: Diphenhydramine HCL; Lidocaine; Atropine



Possible Naropin side effects in female

Reported by a physician from South Africa on 2012-01-19

Patient: female, weighing 58.0 kg (127.6 pounds)

Reactions: Anaphylactic Shock, Blood Pressure Abnormal

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Naropin

Other drugs received by patient: Hyalase; Midazolam HCL



Possible Naropin side effects in female

Reported by a physician from France on 2011-12-13

Patient: female

Reactions: Anaphylactic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Ketamine HCL
    Indication: General Anaesthesia
    Start date: 2011-08-16
    End date: 2011-08-16

Ketamine HCL
    Start date: 2011-08-16
    End date: 2011-08-16

Midazolam
    Indication: General Anaesthesia
    Start date: 2011-08-16
    End date: 2011-08-16

Naropin
    Indication: General Anaesthesia
    Start date: 2011-08-16
    End date: 2011-08-16

Nimbex
    Indication: General Anaesthesia
    Start date: 2011-08-16
    End date: 2011-08-16

Sufentanil Citrate
    Indication: General Anaesthesia
    Start date: 2011-08-16
    End date: 2011-08-16



Possible Naropin side effects in female

Reported by a physician from South Africa on 2011-12-02

Patient: female

Reactions: Anaphylactic Shock, Blood Pressure Abnormal

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Naropin

Other drugs received by patient: Midazolam HCL; Hyalase



Possible Naropin side effects in female

Reported by a physician from France on 2011-11-28

Patient: female

Reactions: Anaphylactic Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Celocurine
    Indication: Induction of Anaesthesia
    Start date: 2011-05-04
    End date: 2011-05-04

Ketamine HCL
    Start date: 2011-05-04
    End date: 2011-05-04

Midazolam HCL
    Start date: 2011-05-04
    End date: 2011-05-04

Naropin
    Start date: 2011-05-04
    End date: 2011-05-04

Propofol
    Start date: 2011-05-04
    End date: 2011-05-04

Sufenta Preservative Free
    Start date: 2011-05-04
    End date: 2011-05-04

Other drugs received by patient: Levothyroxine Sodium; Esomeprazole; Ramipril; Amlodipine; Acetaminophen; Mianserine



Possible Naropin side effects in female

Reported by a physician from France on 2011-11-21

Patient: female

Reactions: Anaphylactic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Augmentin
    Indication: Prophylaxis
    Start date: 2011-01-17
    End date: 2011-01-17

Naropin
    Indication: Analgesic Therapy
    Start date: 2011-01-17
    End date: 2011-01-17

Other drugs received by patient: Remifentanil; Prazepam; Etomidate; Ventolin; Renagel; Tracrium; Tranxene; Imovane

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017